Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients

Acta Psychiatrica Scandinavica

Volumn 107, Issue 4, 2003, Pages 260-267

  Baethge, Christopher ^a   Smolka, M N ^b   Gruschka, P ^c   Berghofer A ^d   Schlattmann, P ^a   Bauer, M ^d   Altshuler, L ^e   Grof, P ^f   Muller Oerlinghausen B ^g  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF OTTAWA   (Canada)

^g Drug Commn of the Ger Med Assoc   (Germany)

Author keywords

Bipolar disorder; Carbamazepine; Course; Kindling; Lithium; Outcome; Prophylaxis

Indexed keywords

CARBAMAZEPINE; LITHIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; LATENT PERIOD; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MORBIDITY; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; SCHOOL CHILD; TREATMENT OUTCOME;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LITHIUM CHLORIDE; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0242416550     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2003.02057.x     Document Type: Article

References (31)

1. GROF P, ALDA M, GROF E, FOX D, CAMERON P. The challenge of predicting response to stabilizing lithium treatment. The importance of patient selection. Br J Psychiatry 1993;163(Suppl. 21):16-19.
2. ABOU-SALEH MT. Who responds to prophylactic lithium therapy? Br J Psychiatry 1993;163(Suppl. 21):20-26.
3. MAJ M, PIROZZI R, MAGLIANO L, BARTOLI L. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry 1998;155:30-35.
4. CALABRESE JR, FATEMI SH, KUJAWA M, WOYSHVILLE MJ. Predictors of response to mood stabilizers. J Clin Psychopharmacol 1996;16(Suppl. 1):24S-31S.
5. CORYELL W, TURVEY C, ENDICOTT J et al. Bipolar I affective disorder: predictors of outcome after 15 years. J Affect Disord 1998;50:109-116.
6. POST R. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992;149:999-1010.
7. POST R, WEISS SRB. Neurobiological models of recurrence in mood disorder. In: CHARNEY DS, NESTLER EJ, BUNNEY BS, eds. Neurobiology of mental illness. Oxford: Oxford University Press, 1999;365-384.
8. MANJI HK, MOORE GJ, RAJKOWSKA G, CHEN G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 2000;5:578-593.
9. WATSON S, YOUNG AH. The place of lithium salts in psychiatric practice 50 years on. Curr Opin Psychiatry 2001;14:57-63.
10. GOODWIN FK, GHAEMI SN. Understanding manic-depressive illness. Arch General Psychiatry 1998;55:23-25.
11. FRANCHINI L, ZANARDI R, SMERALDI E, GASPERINI M. Early onset of lithium prophylaxis as a predictor of good long-term outcome. Eur Arch Psychiatry Clin Neurosci 1998;249:227-230.
12. KUSARIC M, ENGELSMANN F. Predictors of lithium treatment responsiveness in bipolar patients. A two-year prospective study. Neuropsychobiology 1998;37:146-149.
13. TONDO L, BALDESSARINI RJ, HENNEN J, FLORIS G. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry 1998;155:638-645.
14. BALDESSARINI RJ, TONDO L, HENNEN J. Treatment delays in bipolar disorders. (Letter) Am J Psychiatry 1999;156:811.
15. BALDESSARINI RJ, TONDO L, HENNEN J, FLORIS G. Latency and episodes before treatment: response to lithium maintenance in bipolar I and II disorders. Bipolar Disord 1999;2:91-97.
16. TONDO L, BALDESSARINI RJ, FLORIS G. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry 2001;178(Suppl. 41):184-190.
17. BECH P. Rating scales for mood disorders. Applicability, consitency and construct validity. Acta Psychiatr Scand 1988;78(Suppl. 345):45-55.
18. BERGHÖFER A, KOSSMANN B, MÜLLER-OERLINGHAUSEN B. Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years. Acta Psychiatr Scand 1996;93:349-354.
19. COPPEN A, ABOU-SALEH MT. Plasma folate and affective morbidity during long term lithium therapy. Br J Psychiatry 1982;141:87-89.
20. STANER L, TRACY A, DRAMAIX M et al. Clinical and psychosocial predictors of recurrence in recovered bipolar and unipolar depressives: a one-year controlled prospective study. Psych Res 1997;69:39-51.
21. O'CONNEL RA, MAYO JA, FLATOW L, CUTHBERTSON B, O'BRIEN B. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991;159:123-129.
22. MAJ M. The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence. Bipolar Disord 2000;2:93-101.
23. EGELAND JA, BLUMENTHAL RL, NEE J, SHARPE L, ENDICOTT J. Reliability and relationship of various ages of onset criteria for major affective disorder. J Affect Disord 1987;12:159-165.
24. GOODWIN FK, JAMISON KR. Course and outcome. In: Good WIN FK, JAMISON KR, eds. Manic depressive illness. New York: Oxford University Press, 1990;127-156.
25. LICHT RW, VESTERGAARD P, RASMUSSEN NA, JEPSEN K, BRODERSEN A, HANSEN PE. A lithium clinic for bipolar patients. 2-year outcome of the first 148 patients. Acta Psychiatr Scand 2001;104:387-390.
26. CORYELL W, WINOKUR G. Course and outcome. In: PAYKEL ES ed. Handbook of affective disorders, 2nd edn. Edinburgh: Churchill Livingstone, 1992;89-108.
27. GASPERINI M, SCHERILLO P, MANFREDONIA NG, FRANCHINI L, SMERALDI E. A study of relapses in subjects with mood disorder on lithium treatment. Eur Neuropsychopharmacol 1993;3:103-110.
28. GROF P, SCHOIJ M, ANGST J, BAASTRUP PC, WEIS P. Methodological problems of prophylactic trials in recurrent affective disorders. Br J Psychiatry 1970;116:599-619.
29. MÜLLER-OERLINGHAUSEN B, AHRENS B, GROF E et al. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand 1992;86:218-222.
30. TONDO L, HENNEN J, BALDESSARINI RJ. Lower suicide risk with tong-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 2001;104:163-172.
31. GELENBERG AJ. Can lithium help to prevent suicide? Acta Psychiatr Scand 2001;104:161-162.